Dong Soon Lee

1.3k total citations
75 papers, 882 citations indexed

About

Dong Soon Lee is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Dong Soon Lee has authored 75 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 23 papers in Genetics and 22 papers in Molecular Biology. Recurrent topics in Dong Soon Lee's work include Acute Myeloid Leukemia Research (31 papers), Multiple Myeloma Research and Treatments (22 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Dong Soon Lee is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Multiple Myeloma Research and Treatments (22 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Dong Soon Lee collaborates with scholars based in South Korea, Ethiopia and United States. Dong Soon Lee's co-authors include Sung‐Soo Yoon, Seon Young Kim, Kyongok Im, Si Nae Park, Jung‐Ah Kim, Sang Mee Hwang, Seonyang Park, Miyoung Kim, Cheolwon Suh and Inho Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Dong Soon Lee

74 papers receiving 870 citations

Peers

Dong Soon Lee

HEMAT

GENET

ONCOL

IMMUN

Carmelo Gurnari Italy

S. Faderl United States

Huiying Qiu China

Radovan Vrḫovac Croatia

Muhammad Shurafa United States

Delia Dima Romania

Nicole A. Carreau United States

Na Xu China

R Neuwírtová Czechia

Yasuyuki Nakano Japan

Carmelo Gurnari Italy

Dong Soon Lee

592 ×1.0

HEMAT

364 ×1.1

324 ×1.3

GENET

151 ×0.7

ONCOL

208 ×1.6

IMMUN

Citations per year, relative to Dong Soon Lee Dong Soon Lee (= 1×) peers Carmelo Gurnari

Countries citing papers authored by Dong Soon Lee

Since Specialization

Citations

This map shows the geographic impact of Dong Soon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Soon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Soon Lee more than expected).

Fields of papers citing papers by Dong Soon Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Soon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Soon Lee. The network helps show where Dong Soon Lee may publish in the future.

Co-authorship network of co-authors of Dong Soon Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Soon Lee. A scholar is included among the top collaborators of Dong Soon Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Soon Lee. Dong Soon Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Dong Soon, et al.. (2024). Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series. Annals of Laboratory Medicine. 44(5). 446–449. 1 indexed citations

Kim, Boram, Moon‐Woo Seong, Dong Soon Lee, et al.. (2023). Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia. Cancer Genetics. 276-277. 36–39. 6 indexed citations

Kim, Sung‐Min, Soonok Kim, Young Eun Lee, et al.. (2023). Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. Human Genomics. 17(1). 13–13. 3 indexed citations

Kim, Sung‐Min, et al.. (2022). Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation. Annals of Laboratory Medicine. 42(5). 590–596. 2 indexed citations

Yun, Hongseok, et al.. (2021). Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma. Leukemia & lymphoma. 63(2). 385–394. 1 indexed citations

Hong, Junshik, Woo Chan Park, Dong‐Yeop Shin, et al.. (2018). Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype. PLoS ONE. 13(12). e0209800–e0209800. 3 indexed citations

Paik, Jin Ho, Ji‐Young Choe, Hyojin Kim, et al.. (2016). Clinicopathological categorization of Epstein–Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leukemia & lymphoma. 58(1). 53–63. 21 indexed citations

Yi, TacGhee, Hyun Joo Lee, Jung-Hee Kim, et al.. (2015). Manufacture of Clinical-Grade Human Clonal Mesenchymal Stem Cell Products from Single Colony Forming Unit-Derived Colonies Based on the Subfractionation Culturing Method. Tissue Engineering Part C Methods. 21(12). 1251–1262. 31 indexed citations

Yoon, Sung‐Soo, Dong Soon Lee, Sang Kyun Sohn, et al.. (2011). Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial. Annals of Hematology. 91(2). 249–256. 11 indexed citations

10.

Kang, Hye Jin, et al.. (2010). A case of myeloid neoplasm with the PDGFRB rearrangement and eosinophilia. The Korean Journal of Internal Medicine. 78(3). 386–390. 2 indexed citations

11.

Kwon, Ji Hyun, Inho Kim, Youngil Koh, et al.. (2010). Clinical course of non-severe aplastic anemia in adults. International Journal of Hematology. 91(5). 770–775. 30 indexed citations

12.

Lee, Sung Sook, Cheolwon Suh, Bong-Seog Kim, et al.. (2010). Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety. Annals of Hematology. 89(9). 905–912. 16 indexed citations

13.

Lee, Jae Hoon, Dong Soon Lee, Je Jung Lee, et al.. (2010). Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party. International Journal of Hematology. 92(1). 52–57. 36 indexed citations

14.

Eom, Hyeon‐Seok, Yeo‐Kyeoung Kim, Joo-Seop Chung, et al.. (2009). Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Annals of Hematology. 89(5). 489–497. 8 indexed citations

15.

Koh, Youngil, Inho Kim, Soo‐Mee Bang, et al.. (2009). Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype. International Journal of Hematology. 90(1). 1–5. 19 indexed citations

16.

Yoon, Yoo‐Seok, Dong Soon Lee, Jin‐Young Jang, et al.. (2008). Analysis of Molecular Cytogenetic Alteration of Pancreatic Cancer Identified by Fluorescent In Situ Hybridization (FISH) and its Clinical Significance. Korean Journal of Hepato-Biliary-Pancreatic Surgery. 12(1). 75–85. 3 indexed citations

17.

Chang, Yoon Hwan, Tae Young Kim, Byoung Kook Kim, et al.. (2007). Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 175(2). 166–168. 13 indexed citations

18.

Lee, Dong Soon, Yun‐Song Lee, Young Ree Kim, et al.. (2003). A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Genes Chromosomes and Cancer. 37(3). 291–299. 22 indexed citations

19.

Lee, Young Kyung, et al.. (2002). Clinical Implication of the Deletion Status of ABL-BCR on Derivative Chromosome 9 in Chronic Myelogenous Leukemia. The Korean Journal of Laboratory Medicine. 22(6). 373–381. 3 indexed citations

20.

Kim, Hee‐Jin, et al.. (2002). A study on 289 consecutive Korean patients with acute leukaemias revealed fluorescence in situ hybridization detects the MLL translocation without cytogenetic evidence both initially and during follow‐up. British Journal of Haematology. 119(4). 930–939. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact